Key Points
Mucosal Melanoma of the head and neck has a very poor prognosis.
Structured treatment directed at these malignancies remains variable due
to low incidence of disease. Surgery, radiotherapy, and chemotherapy
remain the mainstay of treatment. With limited literature, Immunotherapy
demonstrates a promising aspect of treatment in prolonging survival
rates in these malignancies. Further trials are necessary to prove
efficiency of immunotherapy.